AES Press Releases
Univ. of Colorado Professor Amy R. Brooks-Kayal, M.D.
Named First Vice President of American Epilepsy Society
Washington, D.C., December 9, 2013 – Amy R. Brooks-Kayal, M.D., Professor with Tenure of Pediatrics, Neurology and Pharmaceutical Sciences at the University of Colorado School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences, and Ponzio Family Chair and Chief of Pediatric Neurology at Children’s Hospital Colorado, over the weekend was elected first vice-president of the American Epilepsy Society (AES), during the Society’s 67th annual meeting and scientific conference at the Washington (DC) Convention Center.
AES is the 3,000-member society of physicians, scientists and allied healthcare professionals dedicated to the prevention, treatment, and cure of epilepsy. Dr. Brooks-Kayal’s new AES board position puts her in line to head the organization at the end of the current president’s term in office.
Dr. Brooks-Kayal is a practicing epileptologist at Children’s Hospital Colorado. She also leads an NIH-funded research program focused on the molecular mechanisms underlying epilepsy and the development of new targeted- therapies for epilepsy prevention and disease modification.
As an active volunteer, Dr. Brooks-Kayal has served as chair of the AES Scientific Program Committee, and as a member of the Board of Directors, Nominating Committee, and Governance Committee. She currently is a member of the AES Awards Committee and chair of the Merritt-Putnam Committee.
Dr. Brooks-Kayal served on the executive committee of the American Neurological Association, as a councilor for the Professors of Child Neurology, and has served on various committees for the Child Neurology Society and the Society for Neuroscience. She organized and chaired sessions on epilepsy co-morbidities for the NIH-sponsored conference on curing epilepsy in 2007 and 2013, and served as co-chair and steward for the NINDS epilepsy benchmark on epilepsy co-morbidities, as well as chair of the working group on co-morbidities for the ILAE/AES workshop on preclinical epilepsy therapy discovery.
The newly elected first vice president was trained in medicine and science at Johns Hopkins University, the University of Pennsylvania, and Children’s Hospital of Philadelphia. She has served on the scientific advisory boards for Citizens United for Research in Epilepsy (CURE) and for the National EpiFellows Foundation. Dr. Brooks-Kayal is a past associate editor of the journal Epilepsia, and currently reviews for several other scientific journals.
The epilepsies affect 50 million people worldwide, including three million in the United States. The disorder can have a single specific, well-defined cause, such as a head injury, or manifest as a syndrome with a complex of symptoms. It is the third most common neurological disorder after Alzheimer’s disease and stroke.
About the American Epilepsy Society (AES)
The American Epilepsy Society, based in West Hartford, Conn., seeks to advance and improve the treatment of epilepsy through the promotion of epilepsy research and education for healthcare professionals. Society membership includes physicians and scientists who study and treat epilepsy (epileptologists) and allied professionals who care for people with seizure disorders.
Peter Van Haverbeke, AES Media Relations, cell 703-927-9639
Natalie Judd, Big Voice Communications, cell 203-605-9515, office 203-389-5223
203.389.5223 - email@example.com